Compare iShares MSCI Singapore ETF (EWS) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Singapore ETF vs DENTSPLY SIRONA Inc — how do they compare? iShares MSCI Singapore ETF trades at $31.77, while DENTSPLY SIRONA Inc trades at $13.85 (market cap $2.68B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while iShares MSCI Singapore ETF pays none, and iShares MSCI Singapore ETF is trading nearer its 52-week high, DENTSPLY SIRONA Inc nearer its low. Which is the better fit depends on your goals.
| EWS | XRAY | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $32.09 | $16.85 |
52-Week Low | $26.47 | $9.64 |
Market Cap | — | $2.68B |
Enterprise Value | — | $4.83B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWS trades at $31.825, up 0.62% with strong technical momentum as moving averages signal bullish alignment. The ETF benefits from Singapore's economic resilience and AI-driven growth narrative, though key financial ratios remain undisclosed. Recent news highlights Singapore's strategic positioning in Asian markets and financial sector strength, with a dividend of $0.52 scheduled for June 2026.
Outlook remains positive given technical strength and regional economic tailwinds, but overbought RSI readings suggest near-term consolidation risk. The concentrated financials exposure (54% of holdings) ties performance to banking sector stability, while AI infrastructure investments offer growth catalysts. Investors should monitor Singapore's economic policies and global market volatility.
XRAY trades at $13.76, up 8.35% in 24 hours, with technical indicators showing a bullish trend. The stock has missed earnings estimates for three consecutive quarters, with Q2 2026 EPS expected at $0.36. Revenue declined to $3.68 billion in 2025, and the company reported a net loss of $598 million. Recent news highlights include distribution expansions and new AI-enabled product launches, while analyst sentiment remains mixed with a consensus price target of $13.33.
The outlook for XRAY is cautious due to persistent earnings misses and negative profitability, though technical momentum and strategic initiatives offer some upside potential. Key risks include margin pressure, high debt levels, and soft European demand. Investors should weigh the bullish technical signals against fundamental weaknesses before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Singapore ETF
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
